Dianthus Therapeutics Inc (DNTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 284 | 396 | 193 | 1,163 | 1,326 |
| Gross Profit | 284 | 396 | 193 | 1,163 | 1,326 |
| Operating Expenses | 69,825 | 40,684 | 35,120 | 34,340 | 33,242 |
| Operating Income | -69,541 | -40,288 | -34,927 | -33,177 | -31,916 |
| Other Income | 5,109 | 3,523 | 3,298 | 3,666 | 3,476 |
| Pre-tax Income | -64,432 | -36,765 | -31,629 | -29,511 | -28,440 |
| Net Income Continuous | -64,432 | -36,765 | -31,629 | -29,511 | -28,440 |
| Net Income | $-64,432 | $-36,765 | $-31,629 | $-29,511 | $-28,440 |
| EPS Basic Total Ops | -1.53 | -0.97 | -0.88 | -0.82 | -0.76 |
| EPS Basic Continuous Ops | -1.52 | -0.97 | -0.88 | -0.82 | -0.77 |
| EPS Diluted Total Ops | -1.53 | -0.97 | -0.88 | -0.82 | -0.76 |
| EPS Diluted Continuous Ops | -1.52 | -0.97 | -0.88 | -0.82 | -0.77 |
| EPS Diluted Before Non-Recurring Items | -1.43 | -0.97 | -0.88 | -0.82 | -0.81 |
| EBITDA(a) | $-70,299 | $-42,500 | $-35,926 | $-34,943 | $-34,575 |